trading pattern, page-63

gkara,

I'll pay that one son :)

Still to this day, why do members who do not hold a stock, come in and take a swipe at researchers who are trying to unlock the confidential trials biotech/pharma companies take on? The researchers post 'their' findings and again we the public can take it with a grain of salt or further our knowledge on a stock.

gkara, I have a feeling you may be in for a shock on OBJ in 2012. I Suggest you venture here for some DYOR rather than take a cheap shot, because it does your creditability little.

http://www.obj.com.au/investor-relations-2/